- Home
- ENLV vs ICCM Comparison
ENLV vs ICCM Comparison
Compare ENLV & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENLV | ICCM |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 3.6M |
| IPO Year | 2014 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ENLV | ICCM |
|---|---|---|
| Price | $1.29 | $0.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $22.67 |
| AVG Volume (30 Days) | ★ 1.6M | 101.8K |
| Earning Date | 11-17-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $27.11 |
| Revenue Next Year | N/A | $104.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $0.13 |
| 52 Week High | $7.64 | $9.54 |
Technical Indicators
Market Signals| Indicator | ENLV | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 54.08 | 19.72 |
| Support Level | $0.84 | $0.22 |
| Resistance Level | $2.89 | $0.74 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 40.66 | 15.26 |
Price Performance
Historical ComparisonAbout ENLV Enlivex Therapeutics Ltd.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.